Today's top medical abstracts
Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: VGX-1027 To Undergo Additional Testing For RA
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: FDA Approves Actemra
D Scott Cunningham MD, PhD, MDLinx Rheumatology
From the Editors: New Clinical-Only Option for MDLinx!
Stephen Smith, MDLinx
  See all
Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Exocrine function in primary Sjögren syndrome: Natural course and prognostic factors
Annals of Rheumatic Diseases, 07/11/08
Print     Email This Article     Save in My Library   Free Abstract
K Haldorsen et al. – This study confirms the previous observations of stable or slightly improved exocrine function over time. High focus scores and low unstimulated whole saliva (UWS) were identified as independent predictors of a worsened exocrine function.

Methods
  • Aim was to assess the natural course of the exocrine function in a larger cohort of Sjögren syndrome (SS) pts, and to address possible predictive factors for a declining exocrine function
  • 141 pts were investigated with the Schirmer I test and UWS
  • Historical data regarding these tests and focus score were collected from the files of 111 pts
  • Median time from diagnosis to f/u investigation was 5.0 yrs

Results
  • Median UWS was unchanged during f/u
  • Median Schirmer I test improved from 5.0 to 7.0 mm/5 min
  • Present Schirmer I test was associated with historical high IgG and IgA, positive SSA and SSB tests and high focus score, and present UWS with historical low C3/C4
  • High focus scores, and low UWS as factors predicting a 30% or more worsening of the Schirmer I test
  • High focus scores predicted a 30% or more worsening of the UWS

 

--- AUTOIMMUNE/HERITABLE TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

--- BASIC SCIENCE/GENETICS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Use of NSAIDs and infection with Helicobacter pylori—what does the rheumatologist need to know?
Rheumatology, 08/28/08

Vitamin D and rheumatoid arthritis: Is there a link?
International Journal of Rheumatic Diseases, 09/26/08

Renal Behcet's disease: An update
Seminars in Arthritis and Rheumatism, 08/11/08


Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.